Nasdaq · CIK 0001533743
PCSA Processa Pharmaceuticals, Inc.
Insider trading from SEC Form 4. Last filing Aug 11, 2026. Close $1.52 on Oct 9, 2026, +13% from the 52-week low and -86% from the high.
In brief
Processa Pharmaceuticals, Inc. (PCSA) has 97 SEC Form 4 filings on file from 11 insiders, the latest filed on Aug 11, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.
45 open-market trades have been scored at PCSA. The newest: Wendy Guy (Chief Administrative Officer) bought $4,701 of stock on Jun 30, 2026, filed Jul 1, 2026, scored 59 (moderate). The largest of the 45 shown: Russell Skibsted (Chief Financial Officer) bought $6,325 on Jun 30, 2026, scored 66 (notable). 5 insiders bought within 14 days of each other around Jun 30, 2026.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
11
with a Form 4 at this company
Price and insider trades, last year
PCSAOct 9, 2026 · close 1.52
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Processa Pharmaceuticals, Inc., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 59Moderate | Wendy Guy Chief Administrative Officer buy | $4,701 2,436 shares | +20% | +4% from low-84% from high | |
| 56Moderate | Patrick Lin Chief Business - Strategy Off buy | $4,065 2,106 shares | +19% | +4% from low-84% from high | |
| 69Notable | George K Ng Chief Executive Officer buy | $5,900 3,057 shares | +25% | +6% from low-84% from high | |
| 56Moderate | David Young Pres. Research & Development buy | $4,885 2,531 shares | +13% | +4% from low-84% from high | |
| 66Notable | Russell Skibsted Chief Financial Officer buy | $6,325 3,277 shares | +24% | +4% from low-84% from high | |
| 49Moderate | Wendy Guy Chief Administrative Officer buy | $4,702 2,118 shares | +22% | +19% from low-82% from high | |
| 46Moderate | Patrick Lin Chief Business - Strategy Off buy | $4,065 1,831 shares | +20% | +19% from low-82% from high | |
| 59Moderate | George K Ng Chief Executive Officer buy | $5,472 2,465 shares | +25% | +19% from low-82% from high | |
| 56Moderate | Russell Skibsted Chief Financial Officer buy | $5,892 2,654 shares | +25% | +19% from low-82% from high | |
| 46Moderate | David Young Pres. Research & Development buy | $4,589 2,067 shares | +12% | +19% from low-82% from high | |
| 49Moderate | Wendy Guy Chief Administrative Officer buy | $4,701 1,829 shares | +23% | +38% from low-79% from high | |
| 49Moderate | Patrick Lin Chief Business - Strategy Off buy | $4,066 1,582 shares | +21% | +38% from low-79% from high | |
| 59Moderate | George K Ng Chief Executive Officer buy | $5,472 2,129 shares | +27% | +38% from low-79% from high | |
| 56Moderate | Russell Skibsted Chief Financial Officer buy | $5,890 2,292 shares | +27% | +38% from low-79% from high | |
| 46Moderate | David Young Pres. Research & Development buy | $4,590 1,786 shares | +12% | +38% from low-79% from high | |
| 49Moderate | Wendy Guy Chief Administrative Officer buy | $4,702 1,583 shares | +25% | +60% from low-75% from high | |
| 49Moderate | Patrick Lin Chief Business - Strategy Off buy | $4,066 1,369 shares | +22% | +60% from low-75% from high | |
| 59Moderate | George K Ng Chief Executive Officer buy | $5,474 1,843 shares | +31% | +60% from low-75% from high | |
| 56Moderate | Russell Skibsted Chief Financial Officer buy | $5,892 1,984 shares | +31% | +60% from low-75% from high | |
| 46Moderate | David Young Pres. Research & Development buy | $4,589 1,545 shares | +11% | +60% from low-75% from high | |
| 49Moderate | Sian Bigora Chief Development Officer buy | $5,341 1,971 shares | +36% | +46% from low-77% from high | |
| 63Notable | George K Ng Chief Executive Officer buy | $5,474 1,843 shares | +86% | +60% from low-75% from high | |
| 49Moderate | Sian Bigora Chief Development Officer buy | $5,342 1,986 shares | +36% | +46% from low-77% from high | |
| 49Moderate | Wendy Guy Chief Administrative Officer buy | $4,702 1,748 shares | +37% | +46% from low-77% from high | |
| 49Moderate | Patrick Lin Chief Business - Strategy Off buy | $4,065 1,511 shares | +32% | +46% from low-77% from high | |
| 63Notable | George K Ng Chief Executive Officer buy | $5,471 2,034 shares | +51% | +46% from low-77% from high | |
| 60Notable | Russell Skibsted Chief Financial Officer buy | $5,891 2,190 shares | +51% | +46% from low-77% from high | |
| 46Moderate | David Young Pres. Research & Development buy | $4,589 1,706 shares | +14% | +46% from low-77% from high | |
| 56Moderate | George K Ng Chief Executive Officer buy | $5,415 2,136 shares | - | +36% from low-79% from high | |
| 63Notable | George K Ng Chief Executive Officer buy | $5,474 1,843 shares | +86% | +60% from low-75% from high | |
| 49Moderate | Sian Bigora Chief Development Officer buy | $5,343 1,799 shares | +48% | +60% from low-75% from high | |
| 53Moderate | Wendy Guy Chief Administrative Officer buy | $4,702 1,583 shares | +51% | +60% from low-75% from high | |
| 49Moderate | Patrick Lin Chief Business - Strategy Off buy | $4,066 1,369 shares | +41% | +60% from low-75% from high | |
| 63Notable | George K Ng Chief Executive Officer buy | $5,474 1,843 shares | +51% | +60% from low-75% from high | |
| 60Notable | Russell Skibsted Chief Financial Officer buy | $5,892 1,984 shares | +85% | +60% from low-75% from high | |
| 46Moderate | David Young Pres. Research & Development buy | $4,589 1,545 shares | +15% | +60% from low-75% from high | |
| 48Moderate | James R Neal director buy | $2,000 789 shares | +2721% | +36% from low-79% from high | |
| 48Moderate | Khoso Baluch director buy | $5,752 2,269 shares | +4052% | +36% from low-79% from high | |
| 48Moderate | Sian Bigora Chief Development Officer buy | $5,341 2,107 shares | +131% | +36% from low-79% from high | |
| 48Moderate | Wendy Guy Chief Administrative Officer buy | $4,700 1,854 shares | +148% | +36% from low-79% from high | |
| 48Moderate | Patrick Lin Chief Business - Strategy Off buy | $4,064 1,603 shares | +91% | +36% from low-79% from high | |
| 58Moderate | George K Ng Chief Executive Officer buy | $5,415 2,136 shares | +141% | +36% from low-79% from high | |
| 48Moderate | Geraldine Pannu director buy | $5,253 2,072 shares | +1786% | +36% from low-79% from high | |
| 53Moderate | Russell Skibsted Chief Financial Officer buy | $5,891 2,324 shares | - | +36% from low-79% from high | |
| 44Moderate | David Young Pres. Research & Development buy | $4,588 1,810 shares | +21% | +36% from low-79% from high |
Transactions
The newest 50 of 113 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 8, 2026 | George K Ng Chief Executive Officer | MOption exercise Common Stock | +1,600 | - | - | 17,092 | Aug 11, 2026 |
| Aug 8, 2026 | George K Ng Chief Executive Officer | MOption exercise Restricted Stockderivative | -1,600 | $0.00 | $0 | 19,624 | Aug 11, 2026 |
| Jul 28, 2026 | Sheila Gujrathi director | AGrant or award Series A Preferred Stockderivative | +70,812 | - | - | 70,812 | Jul 30, 2026 |
| Jul 28, 2026 | Sheila Gujrathi director | AGrant or award Series A Preferred Stockderivativeindirect: By SilverArc Private Fund I, L.P. | +12,311 | - | - | 12,311 | Jul 30, 2026 |
| Jul 26, 2026 | Khoso Baluch director | AGrant or award Restricted Stock Unitsderivative | +33,500 | $0.00 | $0 | 38,749 | Jul 28, 2026 |
| Jul 26, 2026 | James R Neal director | AGrant or award Restricted Stock Unitsderivative | +62,221 | $0.00 | $0 | 67,470 | Jul 28, 2026 |
| Jul 26, 2026 | Russell Skibsted Chief Financial Officer | AGrant or award Restricted Stock Unitsderivative | +11,883 | $0.00 | $0 | 17,323 | Jul 28, 2026 |
| Jul 26, 2026 | Geraldine Pannu director | AGrant or award Restricted Stock Unitsderivative | +33,500 | $0.00 | $0 | 38,749 | Jul 28, 2026 |
| Jul 26, 2026 | Wendy Guy Chief Administrative Officer | AGrant or award Restricted Stock Unitsderivative | +9,450 | $0.00 | $0 | 11,669 | Jul 28, 2026 |
| Jul 26, 2026 | Patrick Lin Chief Business - Strategy Off | AGrant or award Restricted Stock Unitsderivative | +8,450 | $0.00 | $0 | 11,389 | Jul 28, 2026 |
| Jul 26, 2026 | George K Ng Chief Executive Officer | AGrant or award Restricted Stock Unitsderivative | +9,384 | $0.00 | $0 | 21,224 | Jul 28, 2026 |
| Jul 26, 2026 | Justin W Yorke director | AGrant or award Restricted Stock Unitsderivative | +33,500 | $0.00 | $0 | 38,749 | Jul 28, 2026 |
| Jun 30, 2026 | David Young Pres. Research & Development | POpen-market purchase Common Stock | +2,531 | $1.93 | $4,885 | 21,729 | Jul 1, 2026 |
| Jun 30, 2026 | Russell Skibsted Chief Financial Officer | POpen-market purchase Common Stock | +3,277 | $1.93 | $6,325 | 16,689 | Jul 1, 2026 |
| Jul 1, 2026 | George K Ng Chief Executive Officer | POpen-market purchase Common Stock | +3,057 | $1.93 | $5,900 | 15,492 | Jul 1, 2026 |
| Jun 30, 2026 | Wendy Guy Chief Administrative Officer | POpen-market purchase Common Stock | +2,436 | $1.93 | $4,701 | 14,394 | Jul 1, 2026 |
| Jun 30, 2026 | Patrick Lin Chief Business - Strategy Off | POpen-market purchase Common Stock | +2,106 | $1.93 | $4,065 | 13,113 | Jul 1, 2026 |
| Jun 26, 2026 | Khoso Baluch director | MOption exercise Common Stock | +203 | - | - | 2,528 | Jun 30, 2026 |
| Jun 26, 2026 | James R Neal director | MOption exercise Common Stock | +203 | - | - | 1,021 | Jun 30, 2026 |
| Jun 26, 2026 | Geraldine Pannu director | MOption exercise Common Stock | +203 | - | - | 2,391 | Jun 30, 2026 |
| Jun 26, 2026 | Justin W Yorke director | MOption exercise Common Stock | +203 | - | - | 353 | Jun 30, 2026 |
| Jun 26, 2026 | Khoso Baluch director | MOption exercise Restricted Stockderivative | -203 | $0.00 | $0 | 5,249 | Jun 30, 2026 |
| Jun 26, 2026 | James R Neal director | MOption exercise Restricted Stockderivative | -203 | $0.00 | $0 | 5,249 | Jun 30, 2026 |
| Jun 26, 2026 | Geraldine Pannu director | MOption exercise Restricted Stockderivative | -203 | $0.00 | $0 | 5,249 | Jun 30, 2026 |
| Jun 26, 2026 | Justin W Yorke director | MOption exercise Restricted Stockderivative | -203 | $0.00 | $0 | 5,249 | Jun 30, 2026 |
| Jun 15, 2026 | Patrick Lin Chief Business - Strategy Off | POpen-market purchase Common Stock | +1,831 | $2.22 | $4,065 | 11,007 | Jun 16, 2026 |
| Jun 15, 2026 | Wendy Guy Chief Administrative Officer | POpen-market purchase Common Stock | +2,118 | $2.22 | $4,702 | 11,958 | Jun 16, 2026 |
| Jun 15, 2026 | George K Ng Chief Executive Officer | POpen-market purchase Common Stock | +2,465 | $2.22 | $5,472 | 12,435 | Jun 16, 2026 |
| Jun 15, 2026 | Russell Skibsted Chief Financial Officer | POpen-market purchase Common Stock | +2,654 | $2.22 | $5,892 | 13,412 | Jun 16, 2026 |
| Jun 15, 2026 | David Young Pres. Research & Development | POpen-market purchase Common Stock | +2,067 | $2.22 | $4,589 | 19,198 | Jun 16, 2026 |
| May 29, 2026 | Patrick Lin Chief Business - Strategy Off | POpen-market purchase Common Stock | +1,582 | $2.57 | $4,066 | 9,176 | Jun 1, 2026 |
| May 29, 2026 | George K Ng Chief Executive Officer | POpen-market purchase Common Stock | +2,129 | $2.57 | $5,472 | 9,970 | Jun 1, 2026 |
| May 29, 2026 | Russell Skibsted Chief Financial Officer | POpen-market purchase Common Stock | +2,292 | $2.57 | $5,890 | 10,758 | Jun 1, 2026 |
| May 29, 2026 | David Young Pres. Research & Development | POpen-market purchase Common Stock | +1,786 | $2.57 | $4,590 | 17,131 | Jun 1, 2026 |
| May 29, 2026 | Wendy Guy Chief Administrative Officer | POpen-market purchase Common Stock | +1,829 | $2.57 | $4,701 | 9,840 | Jun 1, 2026 |
| May 15, 2026 | Wendy Guy Chief Administrative Officer | POpen-market purchase Common Stock | +1,583 | $2.97 | $4,702 | 8,011 | May 19, 2026 |
| May 15, 2026 | Patrick Lin Chief Business - Strategy Off | POpen-market purchase Common Stock | +1,369 | $2.97 | $4,066 | 7,594 | May 19, 2026 |
| May 15, 2026 | George K Ng Chief Executive Officer | POpen-market purchase Common Stock | +1,843 | $2.97 | $5,474 | 7,841 | May 19, 2026 |
| May 15, 2026 | Russell Skibsted Chief Financial Officer | POpen-market purchase Common Stock | +1,984 | $2.97 | $5,892 | 8,466 | May 19, 2026 |
| May 15, 2026 | David Young Pres. Research & Development | POpen-market purchase Common Stock | +1,545 | $2.97 | $4,589 | 15,345 | May 19, 2026 |
| Apr 30, 2026 | Sian Bigora Chief Development Officer | POpen-market purchase Common Stock | +1,971 | $2.71 | $5,341 | 7,481 | May 19, 2026 |
| Apr 15, 2026 | George K Ng Chief Executive Officer | POpen-market purchase Common Stock | +1,843 | $2.97 | $5,474 | 3,979 | May 19, 2026 |
| Apr 30, 2026 | Sian Bigora Chief Development Officer | POpen-market purchase Common Stock | +1,986 | $2.69 | $5,342 | 7,496 | May 1, 2026 |
| Apr 30, 2026 | Wendy Guy Chief Administrative Officer | POpen-market purchase Common Stock | +1,748 | $2.69 | $4,702 | 6,441 | May 1, 2026 |
| Apr 30, 2026 | Patrick Lin Chief Business - Strategy Off | POpen-market purchase Common Stock | +1,511 | $2.69 | $4,065 | 6,236 | May 1, 2026 |
| Apr 30, 2026 | George K Ng Chief Executive Officer | POpen-market purchase Common Stock | +2,034 | $2.69 | $5,471 | 6,013 | May 1, 2026 |
| Apr 30, 2026 | Russell Skibsted Chief Financial Officer | POpen-market purchase Common Stock | +2,190 | $2.69 | $5,891 | 6,498 | May 1, 2026 |
| Apr 30, 2026 | David Young Pres. Research & Development | POpen-market purchase Common Stock | +1,706 | $2.69 | $4,589 | 13,813 | May 1, 2026 |
| Mar 31, 2026 | George K Ng Chief Executive Officer | POpen-market purchase Common Stock | +2,136 | $2.54 | $5,415 | 2,136 | Apr 30, 2026 |
| Apr 15, 2026 | George K Ng Chief Executive Officer | POpen-market purchase Common Stock | +1,843 | $2.97 | $5,474 | 3,979 | Apr 30, 2026 |
50 of 113 rows shown.
Insiders
Everyone who has filed a Form 4 here.
- Khoso Baluchdirector
- Sian BigoraChief Development Officer
- Sheila Gujrathidirector
- Wendy GuyChief Administrative Officer
- Patrick LinChief Business - Strategy Off
- James R Nealdirector
- George K NgChief Executive Officer
- Geraldine Pannudirector
- Russell SkibstedChief Financial Officer
- Justin W Yorkedirector
- David YoungPres. Research & Development
Questions about PCSA
Answered from the filings on this page, as of the latest one.
Are insiders buying PCSA?
No. In the last 90 days no insider at Processa Pharmaceuticals, Inc. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.
Who was the last insider to trade PCSA on the open market?
Wendy Guy (Chief Administrative Officer) bought $4,701 of PCSA on Jun 30, 2026 and filed the Form 4 on Jul 1, 2026. InsiderTell scored 59 (moderate), with 5 insiders on the same side within 14 days.
How many insiders file Form 4 at Processa Pharmaceuticals, Inc.?
11 people have filed a Form 4 at Processa Pharmaceuticals, Inc., among them Khoso Baluch (director), Sian Bigora (Chief Development Officer), Sheila Gujrathi (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.